Sarah Cannon Research Institute
Angie Medina Galeaz currently holds the position of Clinical Study Coordinator and Data Coordinator at Sarah Cannon Research Institute since June 2023. Prior experience includes a Medical Writing Intern role at St. Jude Children's Research Hospital from June 2022 to May 2023. Angie gained leadership experience at Lipscomb University through multiple roles, including Orientation Leader, Executive Secretary, and Admissions Ambassador, where responsibilities included strategic media planning, event management, and fostering relationships with prospective students. Angie earned a Bachelor of Science in Biology from Lipscomb University in May 2023 and is currently pursuing a Master of Science in Biomolecular Science at the same institution, expected to graduate in August 2024.
This person is not in the org chart
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.